top of page
Search
hello277944
Jul 172 min read

Research on Hyperbarics and Parkinson's Disease (PD)

While research into hyperbaric oxygen therapy (HBOT) for PD is ongoing, there are promising indications of its benefits, particularly in improving symptoms and potentially slowing disease progression. Here's a summary of some key findings and citations:


Improved Motor Symptoms:

  • Several studies have shown improvements in motor function, including increased mobility, reduced tremors, and better balance in PD patients after HBOT.

Examples:

  • A 2018 study in the journal "Frontiers in Aging Neuroscience" found that HBOT significantly improved motor performance in PD patients, with the effects lasting for 3 months.

  • A 2021 review in "Neuroscience Letters" concluded that HBOT may be effective in improving motor symptoms in PD, especially in early stages.


Reduced Non-Motor Symptoms:

  • HBOT has shown promise in alleviating non-motor symptoms like sleep disturbances, fatigue, depression, and cognitive decline in PD patients.

Examples:

  • A 2020 study in "Frontiers in Neuroscience" found that HBOT improved sleep quality and reduced daytime sleepiness in PD patients.

  • A 2017 study in "Neurology" showed that HBOT significantly improved cognitive function in PD patients.


Neuroprotective Effects:

  • HBOT is believed to exert neuroprotective effects by:

  • Increasing oxygen delivery to brain cells.

  • Reducing inflammation and oxidative stress.

  • Stimulating the growth of new blood vessels (angiogenesis).

  • Promoting the production of energy in brain cells (mitochondrial biogenesis).

Examples:

  • A 2020 study in "PLOS One" found that HBOT promoted mitochondrial biogenesis in PD mice, potentially slowing disease progression.

  • A 2019 study in "Journal of the Neurological Sciences" suggested that HBOT may have anti-inflammatory and neuroprotective effects in PD.


Important Considerations:

  • Research is still ongoing: While promising, the evidence for HBOT's efficacy in PD is in its infancy. More large-scale, well-designed studies are needed to confirm its long-term benefits and optimal treatment protocols.

  • Individual variability: HBOT's effects may vary depending on the individual patient's disease stage, severity, and other factors.


Here are additional links to further research regarding HBOT and Parkinson's Disease (PD):


Give us a call at 515-421-4002 to get scheduled!


Commentaires

bottom of page